Additionally, AGM promotes neuroplasticity by activating melatonin receptors and upregulating brain-derived neurotrophic factor (BDNF) expression, demonstrating notable therapeutic effects in patients with depression linked to sleep disorders and neurofunctional impairments (136). The gene discussed is BDNF; the disease is sleep disorder.